ZA9710515B - N-(imidazolybutyl) benezenesulphonamide derivatives, their preparation and their application in therapeutics. - Google Patents

N-(imidazolybutyl) benezenesulphonamide derivatives, their preparation and their application in therapeutics.

Info

Publication number
ZA9710515B
ZA9710515B ZA9710515A ZA9710515A ZA9710515B ZA 9710515 B ZA9710515 B ZA 9710515B ZA 9710515 A ZA9710515 A ZA 9710515A ZA 9710515 A ZA9710515 A ZA 9710515A ZA 9710515 B ZA9710515 B ZA 9710515B
Authority
ZA
South Africa
Prior art keywords
imidazolybutyl
benezenesulphonamide
therapeutics
derivatives
preparation
Prior art date
Application number
ZA9710515A
Other languages
English (en)
Inventor
Jean Michel Altenburger
Gilbert Lassalle
Valerie Martin
Daniel Galtier
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of ZA9710515B publication Critical patent/ZA9710515B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9710515A 1996-11-22 1997-11-21 N-(imidazolybutyl) benezenesulphonamide derivatives, their preparation and their application in therapeutics. ZA9710515B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614309A FR2756285B1 (fr) 1996-11-22 1996-11-22 Derives de n-(imidazolylbutyle)benzenesulfonamide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
ZA9710515B true ZA9710515B (en) 1998-06-10

Family

ID=9497920

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9710515A ZA9710515B (en) 1996-11-22 1997-11-21 N-(imidazolybutyl) benezenesulphonamide derivatives, their preparation and their application in therapeutics.

Country Status (20)

Country Link
EP (1) EP0946517A1 (fr)
JP (1) JP2001504128A (fr)
KR (1) KR20000069063A (fr)
CN (1) CN1238765A (fr)
AR (1) AR009627A1 (fr)
AU (1) AU5226498A (fr)
BG (1) BG103414A (fr)
BR (1) BR9713291A (fr)
CA (1) CA2270478A1 (fr)
CO (1) CO4910158A1 (fr)
CZ (1) CZ178299A3 (fr)
EE (1) EE9900201A (fr)
FR (1) FR2756285B1 (fr)
HU (1) HUP9904599A2 (fr)
IL (1) IL129546A0 (fr)
NO (1) NO992436L (fr)
SK (1) SK66799A3 (fr)
TR (1) TR199901143T2 (fr)
WO (1) WO1998022443A1 (fr)
ZA (1) ZA9710515B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2783521B1 (fr) * 1998-09-18 2002-04-26 Synthelabo Derives de n-(arginyl) benzenesulfonamide, leur preparation et leur application en therapeutique
FR2806722B1 (fr) * 2000-03-23 2002-05-17 Sanofi Synthelabo Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique
ES2799309T3 (es) 2014-09-29 2020-12-16 Cellix Bio Private Ltd Compuestos y composiciones para el tratamiento de esclerosis múltiple

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2689130B1 (fr) * 1992-03-30 1994-05-27 Synthelabo Derives de 1-[2 (arylsulfonylamino)ethyl-1-oxo] piperidine, leur preparation et leur application en therapeutique.
FR2710066B1 (fr) * 1993-09-14 1995-10-20 Synthelabo Dérivés de 1-[2-amino-5-[1-(triphénylméthyl-1H-imidazol-4-yl]-1-oxopentyl]piperidine, leur préparation et leur utilisation comme intermédiaires de synthèse.
FR2727410B1 (fr) * 1994-11-25 1996-12-20 Synthelabo Chlorures de sulfonyles, leur preparation et leur utilisation comme intermediaires de synthese
FR2728570B1 (fr) * 1994-12-23 1997-04-11 Synthelabo Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique
DE19548797A1 (de) * 1995-12-27 1997-07-03 Thomae Gmbh Dr K Substituierte 2-Amino-imidazole, ihre Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
CZ178299A3 (cs) 1999-08-11
WO1998022443A1 (fr) 1998-05-28
HUP9904599A2 (hu) 2000-06-28
FR2756285A1 (fr) 1998-05-29
EE9900201A (et) 1999-12-15
AR009627A1 (es) 2000-04-26
FR2756285B1 (fr) 1998-12-18
SK66799A3 (en) 2000-02-14
CN1238765A (zh) 1999-12-15
KR20000069063A (ko) 2000-11-25
TR199901143T2 (xx) 1999-08-23
BG103414A (en) 2000-01-31
IL129546A0 (en) 2000-02-29
EP0946517A1 (fr) 1999-10-06
NO992436D0 (no) 1999-05-20
AU5226498A (en) 1998-06-10
NO992436L (no) 1999-07-22
CO4910158A1 (es) 2000-04-24
JP2001504128A (ja) 2001-03-27
CA2270478A1 (fr) 1998-05-28
BR9713291A (pt) 1999-10-26

Similar Documents

Publication Publication Date Title
HK1018780A1 (en) 6-Phenylpyridine-2-ylamine derivatives, the composition and use thereof.
HUP9904051A3 (en) 4-hetaroylpyrazol derivatives, preparation and use thereof as herbicides
HUP9903691A3 (en) Pesticidal karbanilide derivatives, preparation and use thereof
ZA976222B (en) N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use.
ZA947710B (en) Imidazol-4 ylpiperdine derivatives, their preparation and their application in therapeutics.
HUP9801910A3 (en) Dolastatin derivatives, their preparation and use
ZA973708B (en) Benzofuryl derivatives and their use.
SG79212A1 (en) Reactive dyes, their preparation and use
CY2291B1 (en) 1H-pyridoa3,4-buindole-4-carboxamide derivatives preparation and application thereof in therapeutics
AU9633098A (en) Benzoxazine derivatives, preparation and application in therapy
ZA978089B (en) 3,4-diaryloxazolone derivatives, their methods of preparation, and their use in therapeutics.
HUP9904032A3 (en) 1,2,4-benzothiadiazine derivatives,their preparation and use
ZA988921B (en) 3,4-diarylthiazolin-2-one or -2-thione derivatives their methods of preparation and their uses in therapeutics
ZA200001746B (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use.
ZA989664B (en) 3-substituted tetrahydropyrimidinone derivatives, their preparation and use.
SI1141308T1 (sl) Streptokokni proteini skupine B in njihova uporaba
AU5591296A (en) N-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl)benzamide derivatives, their preparation and their application in therapeutics
HUP9904091A3 (en) N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics
ZA972894B (en) Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics.
ZA9810625B (en) Benzylidenepyrazolones, their preparation and use.
ZA977767B (en) Benzylamine derivatives, their preparation and their application in therapeutics.
ZA976619B (en) Benzimidazole derivatives, their preparation and their therapeutic applications.
ZA966616B (en) Benzenesulphonamide derivatives, their preparation and their application in theraphy.
ZA963620B (en) (Het)aryloxy-, -thio- and -aminocrotonates, their preparation and their use.
ZA9710515B (en) N-(imidazolybutyl) benezenesulphonamide derivatives, their preparation and their application in therapeutics.